Sterling Capital Management’s Unicycive Therapeutics UNCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$633 Buy
+135
New +$996 ﹤0.01% 3202

Other funds holding UNCY

Sterling Capital Management's UNCY Position: Q2 2026 in Review

Sterling Capital Management opened a new position in Unicycive Therapeutics (UNCY) in Q2 2026: 135 shares worth $633. The stake represents ﹤0.01% of the portfolio and ranks #3202 among its holdings.

10 funds tracked by Wall St. Rank hold UNCY as of Q2 2026.

  • Sterling Capital Management held 135 shares of Unicycive Therapeutics worth $633 as of Q2 2026.
  • Unicycive Therapeutics was a new Sterling Capital Management position in Q2 2026.
  • Unicycive Therapeutics made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #3202 holding.
  • 10 funds tracked by Wall St. Rank held Unicycive Therapeutics as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.